511 Therapeutics, Inc.

New Filing

CIK: 0001946264·Biotechnology·DELAWARE·Filed: Oct 30, 2026

Total Offering

$1,000,000

Amount Sold

$500,000

Investors

1

First Sale

Oct 21, 2026

Offering Details

Type: Option to Acquire
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2022
Non-Accredited Investors: No

Related Persons

Name	Role
Shuguang Zhang	Related Person
Yancen Lu	Related Person
Uwe B. Sleytr	Related Person
Andrew Marshall	Related Person

Company

511 Therapeutics, Inc.

1770 MASSACHUSETTS AVENUE

CAMBRIDGE, MA, 02140

(617) 818-7126

SEC Filing

0001946264-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.